Health
Investigational Alzheimer’s drug reduces molecular markers of the disease – News-Medical.Net
An investigational Alzheimer’s drug reduced molecular markers of disease and curbed neurodegeneration in the brain, without demonstrating…
An investigational Alzheimer’s drug reduced molecular markers of disease and curbed neurodegeneration in the brain, without demonstrating evidence of cognitive benefit, in a phase 2/3 clinical trial led by researchers at Washington University School of…
Continue Reading
-
General11 hours agoMan arrested after alleged carjackings, dramatic pursuit in Melbourne CBD
-
Noosa News17 hours agoOpera brilliance in Noosa | Noosa Today
-
Business13 hours agoBuy these ASX dividend shares for 4% to 6% yields
-
General14 hours agoSix NRL players named in England rugby league Ashes sqaud, Man of Steel winner not selected